PEAK6 Group’s Dr. Reddy's Laboratories RDY Stock Holding History

PEAK6 Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-272,000	Closed	-$1.94M	–	4671
2017 Q3	$1.94M	Buy	+272,000	New	+$1.96M	0.01%	1411
2016 Q3	–	Sell	-41,000	Closed	-$420K	–	4639
2016 Q2	$420K	Sell	41,000 -14,500	-26%	-$133K	﹤0.01%	2524
2016 Q1	$502K	Buy	55,500 +44,000	+383%	+$393K	﹤0.01%	2289
2015 Q4	$106K	Sell	11,500 -258,000	-96%	-$2.83M	﹤0.01%	3929
2015 Q3	$3.44M	Buy	269,500 +218,500	+428%	+$2.71M	0.02%	1144
2015 Q2	$564K	Buy	+51,000	New	+$563K	﹤0.01%	2628
2014 Q4	–	Sell	-18,500	Closed	-$194K	–	5060
2014 Q3	$194K	Buy	18,500 +6,500	+54%	+$61.1K	﹤0.01%	3334
2014 Q2	$104K	Sell	12,000 -61,500	-84%	-$517K	﹤0.01%	3694
2014 Q1	$645K	Buy	73,500 +22,000	+43%	+$191K	0.01%	2299
2013 Q4	$423K	Buy	51,500 +34,000	+194%	+$269K	﹤0.01%	2828
2013 Q3	$132K	Sell	17,500 -37,000	-68%	-$269K	﹤0.01%	4004
2013 Q2	$412K	Buy	+54,500	New	+$398K	﹤0.01%	2983

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PEAK6 Group's RDY Position: Q1 2018 in Review

PEAK6 Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 4,190 shares — an estimated $31K sold.

PEAK6 Group first reported a position in RDY in Q2 2013 and held it in 11 quarters. The position peaked at $1.55M in Q4 2015. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

PEAK6 Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 4,190 Dr. Reddy's Laboratories shares in Q1 2018, an estimated $31K.
PEAK6 Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 11 quarters.
PEAK6 Group's Dr. Reddy's Laboratories position peaked at $1.55M in Q4 2015.
121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.